Source:http://linkedlifedata.com/resource/pubmed/id/10717250
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2000-5-11
|
pubmed:abstractText |
We assessed Stanniocalcin-1 (STC-1) mRNA expression in human normal tissues, various types of human cancer cell lines, and cancer tissues obtained during surgery. Using a reverse transcriptase-polymerase chain reaction (RT-PCR) assay developed to detect STC-1 mRNA, the transcripts were detected in 20 out of 21 cancer cell lines and in all tumor tissues from various types of cancer. Semi-quantitative analyses with multiplex RT-PCR showed that STC-1 mRNA tended to be enhanced in cancer tissues of hepatocellular carcinoma and colorectal cancer compared to background cancer-free tissues. Analysis of blood samples obtained from 11 patients with hepatocellular carcinoma before, after and during hepatectomy showed STC-1 mRNA expression in 8 out of 11 patients at least one time. Normal donor blood samples (n=31) were all-negative for STC-1 mRNA expression. Our results indicate that STC-1 mRNA might be a useful molecular marker for detection of tumor cells in blood from patients with various types of malignancies.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Hormones,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/teleocalcin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1019-6439
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
799-804
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:10717250-Aged,
pubmed-meshheading:10717250-Carcinoma, Hepatocellular,
pubmed-meshheading:10717250-Glycoproteins,
pubmed-meshheading:10717250-Hormones,
pubmed-meshheading:10717250-Humans,
pubmed-meshheading:10717250-Liver Neoplasms,
pubmed-meshheading:10717250-Male,
pubmed-meshheading:10717250-Middle Aged,
pubmed-meshheading:10717250-Neoplastic Cells, Circulating,
pubmed-meshheading:10717250-RNA, Messenger,
pubmed-meshheading:10717250-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:10717250-Sensitivity and Specificity,
pubmed-meshheading:10717250-Tumor Cells, Cultured,
pubmed-meshheading:10717250-Tumor Markers, Biological
|
pubmed:year |
2000
|
pubmed:articleTitle |
Assessment of Stanniocalcin-1 mRNA as a molecular marker for micrometastases of various human cancers.
|
pubmed:affiliation |
Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|